Latest Poly ADP ribose polymerase Stories
Presentations include first Phase 2 results evaluating investigational compound Veliparib in patients with non-small cell lung cancer NORTH CHICAGO, Ill., Sept.
A University of Maryland study of a rare genetic disorder that causes premature aging and early death may help explain the effects of normal aging on the cardiovascular system.
The Jeffrey Epstein VI Foundation backs the FDA's landmark decision to approve inhibitor cocktails for melanoma. NEW YORK, Feb.
Researchers from the Icahn School of Medicine at Mount Sinai have identified a new molecular mechanism by which cocaine alters the brain's reward circuits and causes addiction.
NEW YORK, Jan.
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer.
Double-strand breaks in DNA happen every time a cell divides and replicates.
The simultaneous inhibition of two separate and seemingly unrelated pathways could potentially provide an effective treatment for women with triple-negative breast cancer.
A new study published in Science May 11 is shedding light on the molecular details of PARP-1, a DNA damage-detecting enzyme that when inhibited has been shown to be effective in fighting cancer and other diseases.